China NMPA Inspection - Jiangxi Pinxin Pharmaceutical Co., Ltd. - December 25, 2020
China NMPA unannounced inspection for Jiangxi Pinxin Pharmaceutical Co., Ltd. published December 25, 2020. The Jiangxi Provincial Drug Administration, operating under the National Medical Products Administration (NMPA) framework, conducted follow-up inspect
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Jiangxi Pinxin Pharmaceutical Co., Ltd. published December 25, 2020. The Jiangxi Provincial Drug Administration, operating under the National Medical Products Administration (NMPA) framework, conducted follow-up inspect
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
cosmetics
ID: ade5e227-6bf9-4c29-8aa3-18f593fc90b3
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox